MEDICILON

contact us jpkrencn

事業内容

事業内容

あなたはここにいる:ホーム > 事業内容

  • 製剤プロセス研究

    製剤プロセス研究

    Different dosage forms and manufacturing process may face different situations and problems in product development. A proper formulation and process should be employed to make sure the formulation and the scaled up process are reasonable and dependable and all the in process steps could be controlled effectively.

  • 一致性評価

    一致性評価

    In response to the national policy to improve the quality of drugs, to adapt to the new situation, Medicilon provide strong technical support for the domestic pharmaceutical enterprises to evaluate the consistency of generic drugs, and thoroughly solve the problem of the consistency evaluation of generic drugs.We have a wealth of experience in the development of generic drugs: have completed a number of generic drug registration; and a number of pharmaceutical companies signed a cooperation agreement.

  • 製剤品質研究

    製剤品質研究

    Our CMC department focuses on establishing large-scale synthetic routes along with formulation development and quality control. Our drug categories can be proprietary drugs or generic drugs. All studies are complied with ICH and CFDA guidelines.

  • GMP臨床サンプルの製造及び包装

    GMP臨床サンプルの製造及び包装

    Medicilon’s packaging can provide single window and double blind clinical trial material labeling options. We can also provide different types of line with current GMP standard clinical production of packaging services based on customer requirements.

  • 組換えキナーゼ生成業務

    組換えキナーゼ生成業務

    Medicilon is a leading provider of comprehensive, high quality recombinant protein and bioprocess services. We offer a variety of recombinant protein expression platforms along with a host of other protein services like chemical protein synthesis, protein refolding and structural biology services.

  • X線に基づく結晶構造生物学

    X線に基づく結晶構造生物学

    Medicilon established a well-developed structural biology research platform. Medicilon is proud as the one firstly provides gene to crystal structure service in China. Medicilon has well-established integrated service platform, which has been certified as an important platform for drug discovery by Shanghai Government.

  • 細胞生物学

    細胞生物学

    Our Discovery Biology department offers services supporting structure-based drug discovery from determination of novel targets to final structures. Our platform is one of the earliest established structural biology platforms in China and has been certified by the Shanghai Government.

  • SeMet メディア販売

    SeMet メディア販売

    Medicilon offers prepackaged M9 selenomethionine (SeMET) growth media kits and packages for growing cell culture in IPTG-inducible bacterial expression systems, leading to the production of SeMET-labeled proteins for crystallographic studies using MAD.